Y-27632二盐酸盐
Y-27632二盐酸盐 性质
熔点 | >260°C (dec.) |
---|---|
沸点 | 462.6±15.0 °C(Predicted) |
密度 | 1.136±0.06 g/cm3(Predicted) |
储存条件 | Keep in dark place,Sealed in dry,2-8°C |
溶解度 | H2O: 14 mg/mL |
形态 | 固体 |
酸度系数(pKa) | 13.53±0.40(Predicted) |
颜色 | 白色 |
稳定性 | 吸湿性 |
Y-27632二盐酸盐 用途与合成方法
ROCK-I 220 nM (Ki) |
ROCK-II 300 nM (Ki) |
PKN 3.1 μM (Ki) |
Citron kinase 5.3 μM (Ki) |
PKCα 73 μM (Ki) |
PKA 25 μM (Ki) |
Y-27632 inhibits the ROCK family of kinases 100 times more potently than other kinases including protein kinase C, cAMP-dependent kinase and myosin light chain kinase. Y-27632 prolongs the lag time and delays the appearance of BrdU-labeled cells in a concentration-dependent manner, delays of about 1 and 4 h are noticed in the Swiss 3T3 cells treated with 10 and 100 μM Y-27632, respectively. Y-27632 promotes neuronal differentiation of adipose tissue-derived stem cells (ADSCs). Compared to 1.0 and 2.5 μM Y-27632 induced groups, percentages of neuroal-like cells achieved a peak in the 5.0 μM Y-27632 induced group.
Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of myoclonic jerks when compare with saline group. Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of clonic convulsions when compare with saline group. Treatment with Dimethylnitrosamine (DMN) causes a significant decrease in rat body and liver weight (DMN-S group) compared with control animals (S-S group). Oral Y27632 (30 mg/kg) essentially prevents this DMN-induced rat body and liver weight loss (DMN-Y group).
Y-27632二盐酸盐 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-10583 | 2 mg | 450 | ||
2024-11-08 | HY-10583 | Y-27632二盐酸盐 | 146986-50-7 | 5mg | 700 |